Lv4
500 积分 2023-03-14 加入
A Randomized, Placebo-Controlled Trial of Pentoxifylline on Erythropoiesis-Stimulating Agent Hyporesponsiveness in Anemic Patients With CKD: The Handling Erythropoietin Resistance With Oxpentifylline (HERO) Trial
3个月前
已完结
Addition of roxadustat to erythropoiesis‐stimulating agent ( ESA ) effectively corrects ESA ‐hyporesponsive anaemia in patients on peritoneal dialysis
3个月前
已完结
Addition of roxadustat to erythropoiesis‐stimulating agent ( ESA ) effectively corrects ESA ‐hyporesponsive anaemia in patients on peritoneal dialysis
3个月前
已完结
Roxadustat for dialysis patients with erythropoietin hypo-responsiveness: a single-center, prospective investigation
3个月前
已完结
A Prospective, Self-Controlled Pilot Study of the Efficacy of Roxadustat for Erythropoietin Hyporesponsiveness in Patients Requiring Chronic Ambulatory Peritoneal Dialysis
3个月前
已完结
Optimizing the dosing regimen of roxadustat in kidney transplant recipients with early post-transplant anemia
3个月前
已完结
A Prospective, Self-Controlled Pilot Study of the Efficacy of Roxadustat for Erythropoietin Hyporesponsiveness in Patients Requiring Chronic Ambulatory Peritoneal Dialysis
3个月前
已完结
A review of Novel Endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An Update
4个月前
已完结
Therapeutic targets for pulmonary arterial hypertension: insights into the emerging landscape
4个月前
已完结
Prognostic significance of erythropoietin expression in human renal cell carcinoma
4个月前
已完结
皖公网安备34019202002308
